Individualize the Treatment of Interstitial Lung Disease
PROGRAM DESCRIPTION Although once considered rare, epidemiologic investigations have revealed interstitial lung disease (ILD) to be significantly more common than previously recognized. Previously, it has been reported that 80.9 per ...
PROGRAM DESCRIPTION
Although once considered rare, epidemiologic investigations have revealed interstitial lung disease (ILD) to be significantly more common than previously recognized. Previously, it has been reported that 80.9 per 100,000 men and 67.2 per 100,000 women suffer from ILD in the US, with 31.5 new cases diagnosed per 100,000 men per year and 26.1 new cases diagnosed per 100,000 women per year. Certain ILDs (eg, sarcoidosis, pulmonary Langerhans cell histiocytosis, and autoimmune-associated lung diseases) appear to develop more frequently during young adulthood, whereas idiopathic pulmonary fibrosis (IPF) occurs most often between the ages of 40 and 70. Both the incidence and associated mortality of ILD increases with age, and consistent with the expansion of elderly populations, recent evidence indicates that the number of new cases diagnosed per year and the mortality rates continue to rise. Hospital Medicine Summit (HMS) is an innovative, multi-topic educational initiative designed specifically for hospital-based healthcare providers (hospitalists, internal medicine physicians, physician assistants, nurse practitioners, pharmacists, and nurses). With significant changes occurring in the healthcare system, there is an increased demand on hospital-based healthcare providers to provide care that impacts patients not only in the acute setting, but as they transition back into the community and are managed in the chronic-care healthcare system.
EDUCATIONAL OBJECTIVES
Upon completion of this educational activity, participants should be able to:Outline a multidisciplinary approach for the differential diagnosis of interstitial lung disease (ILD)Discuss the latest evidence-based guidelines for idiopathic pulmonary fibrosis (IPF) and review strategies for individualized ILD managementDescribe strategies for ensuring adequate clinician-patient communication over the course of ILD management
Read more about this
Write the first review
Join now
to leave a review or read peer reviews!
Resource tags
Show all tags